A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2011
03/23/2011	CN101380417B Preparation for quickly treating urticaria
03/23/2011	CN101259171B Chinese medicine preparation for preventing pigling's yellow-white dysentery and improving immunity
03/23/2011	CN101224200B Novel anti-systematic erythema lupus medicine
03/23/2011	CN101062145B Health drug pillow
03/22/2011	US7910770 3-Isopropoxy-7-methoxy-N-(1H-1,2,3,4-tetrazol-5-yl)-1-benzo[b]thiophene-2-carboxamide; autoimmune diseases such as rheumatoid arthritis, immune thrombocytopenia purpura, systemic lupus erythematosus and Crohn's disease
03/22/2011	US7910741 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
03/22/2011	US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders
03/22/2011	US7910707 Anti-interferon-α antibodies
03/22/2011	US7910617 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound
03/22/2011	US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
03/22/2011	US7910564 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant
03/22/2011	US7910562 Method of delivering genes into antigen presenting cells of the skin
03/22/2011	US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression
03/22/2011	US7910368 Method of extended culture for antigen-specific cytotoxic lymphocytes
03/22/2011	US7910099 Antibodies to VLA-1
03/22/2011	CA2492342C Novel bio-active pyrimidine derivatives
03/22/2011	CA2480273C Ph-sensitive polymer
03/22/2011	CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
03/22/2011	CA2471538C Pyrrolopyrimidines
03/22/2011	CA2460036C Medical devices containing rapamycin analogs
03/22/2011	CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof
03/22/2011	CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/22/2011	CA2379581C Echinacea supplement and method of manufacture
03/22/2011	CA2376797C Administration of non oral androgenic steroids to women
03/22/2011	CA2359334C Bifidobacterium in the treatment of inflammatory disease
03/22/2011	CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea)
03/22/2011	CA2240409C Mammalian cx3c chemokine genes
03/17/2011	WO2011032108A2 Formulation for room temperature stabilization of a live attenuated bacterial vaccine
03/17/2011	WO2011030903A1 Composition for alleviating ultraviolet radiation-induced damage
03/17/2011	WO2011030871A1 N-substituted heteroaryl compounds
03/17/2011	WO2011030851A1 Process for production of natural killer cells
03/17/2011	WO2011029807A1 Ortho substituted pyrimidine compounds as jak inhibitors
03/17/2011	WO2011029804A1 Inhibitors of jak
03/17/2011	WO2011029404A1 Mir-125a for regulating expression of rantes, composition and use thereof
03/17/2011	WO2011029170A1 Process to obtain a homeopathic medicament and use thereof
03/17/2011	WO2011029126A1 Methods and reagents for producing antibodies against autoantigens
03/17/2011	US20110067121 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications
03/17/2011	US20110066111 Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
03/17/2011	US20110065918 New phenylalanine derivatives
03/17/2011	US20110065778 RNA Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (siNA)
03/17/2011	US20110065773 Rna interference mediating small rna molecules
03/17/2011	US20110065760 Compounds for the inhibition of rotamases and use thereof
03/17/2011	US20110065750 Solid Forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and Methods of Making the Same
03/17/2011	US20110065736 Quinazoline derivatives as vegf inhibitors
03/17/2011	US20110065734 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
03/17/2011	US20110065712 Tricyclic compounds and pharmaceutical uses thereof
03/17/2011	US20110065701 Pharmaceutical compounds
03/17/2011	US20110065688 Therapeutic piperazines
03/17/2011	US20110065685 Novel indoles are cannabinoid receptor ligands
03/17/2011	US20110065681 Amide compounds, compositions and uses thereof
03/17/2011	US20110065678 Isoxazolidine derivatives
03/17/2011	US20110065675 Azo dye related small molecule modulators of protein-protein interactions
03/17/2011	US20110065649 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
03/17/2011	US20110065187 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065186 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065180 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/17/2011	US20110065146 Expression of HIV polypeptides and production of virus-like particles
03/17/2011	US20110065138 Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation
03/17/2011	US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases
03/17/2011	US20110065109 Rna interference mediating small rna molecules
03/17/2011	US20110064800 Nanoparticulate and controlled release compositions comprising cyclosporine
03/17/2011	US20110064775 Metallo-organic system for the encapsulation and release of compounds of interest, method for obtaining same and uses thereof
03/17/2011	US20110064771 Plant extracts and uses thereof
03/17/2011	US20110064769 Vv promoter-driven overexpression of recombinant antigens
03/17/2011	US20110064768 Immunogenic Compositions
03/17/2011	US20110064766 Attenuated Vaccine Against Fish Pathogen Francisella Sp.
03/17/2011	US20110064765 Pcv-2 vaccine
03/17/2011	US20110064764 Attenuated Live Triple G Protein Recombinant Rabies Virus Vaccine for Pre- and Post-Exposure Prophylaxis of Rabies
03/17/2011	US20110064762 Protein a compositions and methods of use
03/17/2011	US20110064761 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
03/17/2011	US20110064760 Polypeptides comprising epitopes of hiv gp41 and methods of use
03/17/2011	US20110064759 Method for the Identification of Extracellular Domains of Epstein Barr Virus (EBV) Tumor-Associated Latent Membrane Proteins and for the Selection of Antibody Reagents Reactive Therewith
03/17/2011	US20110064758 Infectious clones of torque teno virus
03/17/2011	US20110064757 Nucleic acid molecules and polypeptides for immune modulation
03/17/2011	US20110064756 Novel sequences of brachyspira, immunogenic compounds, methods for preparation and use thereof
03/17/2011	US20110064754 Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines
03/17/2011	US20110064753 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
03/17/2011	US20110064749 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
03/17/2011	US20110064745 Therapeutic Antibodies, Antibody Fragments And Antibody Conjugates
03/17/2011	US20110064734 Prevention and treatment of amyloidogenic disease
03/17/2011	US20110064731 Use of IL-20 Antagonists for Treating Rheumatoid Arthritis and Osteoporosis
03/17/2011	US20110064726 ANTI IgE ANTIBODIES
03/17/2011	US20110064725 High affinity, anti-human ige antibodies
03/17/2011	US20110064723 Formulation for room temperature stabilization of a live attenuated bacterial vaccine
03/17/2011	US20110064708 Methods And Compositions For The Dietary Management Of Autoimmune Disorders
03/17/2011	US20110064707 Probiotics to improve gut microbiota
03/17/2011	US20110064705 Hemangio colony forming cells and non-engrafting hemangio cells
03/17/2011	US20110064692 Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression
03/17/2011	US20110064689 In situ immunization
03/17/2011	US20110064663 Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use
03/17/2011	CA2773690A1 Protein matrix vaccines of improved immunogenicity
03/17/2011	CA2773426A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes
03/17/2011	CA2773182A1 Inhibitors of jak
03/17/2011	CA2772593A1 Probiotic derived non-viable material for allergy prevention and treatment
03/17/2011	CA2771863A1 Compositions that induce t cell help
03/17/2011	CA2771675A1 Ortho substituted pyrimidine compounds as jak inhibitors
03/17/2011	CA2771334A1 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
03/17/2011	CA2770712A1 Heterocyclic compounds as janus kinase inhibitors
03/16/2011	EP2295606A1 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
03/16/2011	EP2295578A2 Cyp1b1 nucleic acids and methods of use

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 1172